Alpha 2.0
Login Register
» Authors » Jennifer F Morton

Jennifer F Morton

Explore the profile of Jennifer F Morton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 508
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Health Services
Top 10 Co-Authors
Jared M Baeten
Gabrielle OMalley
Elizabeth A Bukusi
Linda-Gail Bekker
Connie Celum
Ariane van der Straten
Josephine Odoyo
Kenneth Ngure
Kenneth K Mugwanya
Victor Omollo
Published In
J Int AIDS Soc
PLoS One
AIDS Behav
Front Reprod Health
BMC Health Serv Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease
Drain P, Niu X, Shapiro A, Magcaba Z, Ngcobo Z, Ngwane M, et al.
EBioMedicine . 2024 Sep; 108:105353. PMID: 39332390
Background: Development of a non-sputum test using readily-obtainable biospecimens remains a global priority for tuberculosis (TB) control. We quantified lipoarabinomannan (LAM) concentrations, a pathogen biomarker for Mycobacterium tuberculosis, in urine,...
2.
Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa
Rousseau E, Sikkema K, Julies R, Mazer K, OMalley G, Heffron R, et al.
J Int AIDS Soc . 2024 May; 27(5):e26254. PMID: 38695101
Introduction: Adolescent girls and young women (AGYW), a priority population for HIV prevention in Africa, show high interest but difficulty in sustained effective use of pre-exposure prophylaxis (PrEP). With ongoing...
3.
A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
Celum C, Seidman D, Travill D, Dehlendorf C, Gumede S, Zewdie K, et al.
J Int AIDS Soc . 2023 Aug; 26(8):e26154. PMID: 37634942
Introduction: African adolescent girls and young women (AGYW) have high rates of HIV acquisition and are a priority population for HIV pre-exposure prophylaxis (PrEP). PrEP implementation has been limited by...
4.
Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa
Rousseau E, Wu L, Heffron R, Baeten J, Celum C, Travill D, et al.
Front Reprod Health . 2023 Jun; 5:1073103. PMID: 37325240
Introduction: Gendered power inequalities impact adolescent girls' and young women's (AGYW) sexual and reproductive health (SRH) outcomes. We investigated the influence of sexual relationship power on AGYW's SRH outcomes, including...
5.
COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave
Tu Y, Green C, Hao L, Greninger A, Morton J, Sights H, et al.
Microbiol Spectr . 2023 Apr; 11(3):e0006423. PMID: 37097146
Appropriate interpretation of various diagnostic tests for COVID-19 is critical, yet the association among rapid antigen tests, reverse transcription (RT)-PCR, and viral culture has not been fully defined. To determine...
6.
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study
Drain P, Dalmat R, Hao L, Bemer M, Budiawan E, Morton J, et al.
J Clin Virol . 2023 Mar; 161:105420. PMID: 36913789
Background: Guidelines for SARS-CoV-2 have relied on limited data on duration of viral infectiousness and correlation with COVID-19 symptoms and diagnostic testing. Methods: We enrolled ambulatory adults with acute SARS-CoV-2...
7.
Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
Hao L, Hsiang T, Dalmat R, Ireton R, Morton J, Stokes C, et al.
Viruses . 2023 Feb; 15(2). PMID: 36851745
New variants of SARS-CoV-2 continue to emerge and evade immunity. We isolated SARS-CoV-2 temporally across the pandemic starting with the first emergence of the virus in the western hemisphere and...
8.
Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya
Velloza J, Roche S, Owidi E, Irungu E, Dollah A, Kwach B, et al.
J Int AIDS Soc . 2023 Feb; 26(2):e26055. PMID: 36739603
Introduction: HIV pre-exposure prophylaxis (PrEP) is an essential prevention strategy being scaled up for priority populations in Kenya, including for HIV serodiscordant couples. The COVID-19 pandemic posed challenges to PrEP...
9.
Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women
OMalley G, Beima-Sofie K, Roche S, Rousseau E, Travill D, Omollo V, et al.
Front Reprod Health . 2022 Oct; 3:668672. PMID: 36303982
Successful integration of pre-exposure prophylaxis (PrEP) with existing reproductive health services will require iterative learning and adaptation. The interaction between the problem-solving required to implement new interventions and health worker...
10.
Qualitative Analysis Using Social Maps to Explore Young Women's Experiences With Social Support of their Oral PrEP Use in Kenya and South Africa
Katz A, Roberts S, Rousseau E, Khoza M, Mogaka F, Bukusi E, et al.
J Assoc Nurses AIDS Care . 2022 Sep; 34(1):45-57. PMID: 36170124
Daily oral pre-exposure prophylaxis (PrEP) adherence is challenging. We explored African adolescent girls and young women's (AGYW) perceptions of the social influencers of their PrEP use and the social influencers'...